AU4384197A - New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds - Google Patents

New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds

Info

Publication number
AU4384197A
AU4384197A AU43841/97A AU4384197A AU4384197A AU 4384197 A AU4384197 A AU 4384197A AU 43841/97 A AU43841/97 A AU 43841/97A AU 4384197 A AU4384197 A AU 4384197A AU 4384197 A AU4384197 A AU 4384197A
Authority
AU
Australia
Prior art keywords
different
group
stand
medicaments
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU43841/97A
Other versions
AU741636B2 (en
Inventor
Nikolaos Dimoudis
Walter-Gunar Friebe
Bernhard Knipp
Uwe Michaelis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medigene AG
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU4384197A publication Critical patent/AU4384197A/en
Application granted granted Critical
Publication of AU741636B2 publication Critical patent/AU741636B2/en
Assigned to MEDIGENE ONCOLOGY GMBH reassignment MEDIGENE ONCOLOGY GMBH Alteration of Name(s) in Register under S187 Assignors: DIMOUDIS, NIKOLAOS, FRIEBE, WALTER-GUNAR, KNIPP, BERNHARD, MICHAELIS, UWE
Assigned to FRIEBE, WALTER-GUNAR, MICHAELIS, UWE, DIMOUDIS, NIKOLAOS, KNIPP, BERNHARD reassignment FRIEBE, WALTER-GUNAR Alteration of Name(s) in Register under S187 Assignors: ROCHE DIAGNOSTICS GMBH
Assigned to MEDIGENE AKTIENGESELLSCHAFT reassignment MEDIGENE AKTIENGESELLSCHAFT Request to Amend Deed and Register Assignors: MEDIGENE ONCOLOGY GMBH
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to new amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds. The subject of the invention is medicaments having the general formula (I) wherein A can mean hydrogen, a group NR1R2, a group NR1(CH2)pNR3R4, a group (C=NH)NH2 or a pyridinyl radical, B and D can be identical or different and stand each for a binding, a C1 to C6-alkylene radical or a group NR5-C2-C6-alkylene, C can mean piperidindiyl or piperazindiyl, W and X are identical or different and stand each for a carbonyl group, Y and Z can be identical or different and stand each for a saturated or unsaturated hydrocarbon radical with 7-24 carbon atoms, R1 to R5 can be identical or different and stand each for hydrogen or a C1 to C6 alkyl radical, m stands for a whole number 0, 1, or 2 and if m = 2 both radicals C independently from another can also mean piperidindiyl and piperazindiyl, n and o can be identical or different and stand each for a whole number 2, 3 or 4 and p means a whole number from 2 to 6, as well as their physiologically compatible salts, with the proviso that no hydrazine derivatives are comprised and that m be not 0, when A means hydrogen or a group (C=NH)NH2 and B and D are identical or different and represent a binding or an alkylene radical.
AU43841/97A 1996-09-12 1997-09-10 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds Ceased AU741636B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19637043 1996-09-12
DE19637043A DE19637043A1 (en) 1996-09-12 1996-09-12 Novel amino alcohol derivatives, processes for their preparation and medicaments and reagents containing these compounds
PCT/EP1997/004944 WO1998011082A1 (en) 1996-09-12 1997-09-10 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds

Publications (2)

Publication Number Publication Date
AU4384197A true AU4384197A (en) 1998-04-02
AU741636B2 AU741636B2 (en) 2001-12-06

Family

ID=7805345

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43841/97A Ceased AU741636B2 (en) 1996-09-12 1997-09-10 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds

Country Status (12)

Country Link
EP (1) EP0927174B1 (en)
JP (1) JP4191251B2 (en)
KR (1) KR20000036063A (en)
CN (1) CN1087293C (en)
AT (1) ATE380798T1 (en)
AU (1) AU741636B2 (en)
BR (1) BR9712818A (en)
CA (1) CA2265765A1 (en)
DE (2) DE19637043A1 (en)
TR (1) TR199901200T2 (en)
WO (1) WO1998011082A1 (en)
ZA (1) ZA978170B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0108876D0 (en) * 2001-04-09 2001-05-30 Novartis Ag Organic Compounds
AU2010207486B2 (en) * 2009-01-26 2013-03-07 Israel Institute For Biological Research Bicyclic heterocyclic spiro compounds
ES2828717T3 (en) 2015-06-24 2021-05-27 Nitto Denko Corp Ionizable Compounds and Compositions and Uses Thereof
US10800635B2 (en) 2017-08-30 2020-10-13 Otis Elevator Company Elevator door wedge monitoring system
CN117003658A (en) * 2020-04-09 2023-11-07 苏州艾博生物科技有限公司 Lipid Nanoparticle Compositions
TW202204622A (en) 2020-04-09 2022-02-01 大陸商蘇州艾博生物科技有限公司 Nucleic acid vaccines for coronavirus
CN115947672B (en) * 2023-01-04 2024-02-27 成都威斯津生物医药科技有限公司 Compounds, liposomes, and drug carriers for delivery of drugs

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3689494A (en) * 1971-03-31 1972-09-05 William R J Simpson N-pyridinealkyl-alkanolamine nitrates
US4158093A (en) * 1977-12-15 1979-06-12 Reilly Tar & Chemical Corporation Process for substituting and dequaternizing pyridylethyl quaternary salts of pyridine and bypyridine bases
JPS6325654A (en) * 1986-07-18 1988-02-03 Fuji Photo Film Co Ltd Color photographic developing solution composition and method for processing silver halide color photographic sensitive material
JPH05232660A (en) * 1992-02-19 1993-09-10 Konica Corp Treatment for silver halide color photographic sensitive material
JP2588339B2 (en) * 1992-06-02 1997-03-05 花王株式会社 Novel diamino diester and method for producing the same
US5334761A (en) * 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
JPH06340598A (en) * 1993-05-28 1994-12-13 Lion Corp New diester diamine compound, intermediate therefor and its production and softening agent
US5491263A (en) * 1993-12-21 1996-02-13 The Dow Chemical Company Aminoethylation process for production of substituted ethylene diamines
FR2717694B1 (en) * 1994-03-22 1996-05-03 Seppic Sa A composition comprising a recombinant plasmid and its uses as a vaccine and medicament.
FR2727679B1 (en) * 1994-12-05 1997-01-03 Rhone Poulenc Rorer Sa NEW TRANSFECTION AGENTS AND THEIR PHARMACEUTICAL APPLICATIONS
US5635487A (en) * 1994-12-29 1997-06-03 Wolff; Jon A. Amphipathic, micellar delivery systems for biologically active polyions
DE19521412A1 (en) * 1995-06-14 1996-12-19 Boehringer Mannheim Gmbh New cationic and polycationic amphiphiles, reagents containing them and their use

Also Published As

Publication number Publication date
EP0927174B1 (en) 2007-12-12
BR9712818A (en) 1999-12-21
TR199901200T2 (en) 1999-10-21
EP0927174A1 (en) 1999-07-07
CN1237161A (en) 1999-12-01
DE59712902D1 (en) 2008-01-24
ATE380798T1 (en) 2007-12-15
JP4191251B2 (en) 2008-12-03
ZA978170B (en) 1999-03-11
AU741636B2 (en) 2001-12-06
JP2001504806A (en) 2001-04-10
CA2265765A1 (en) 1998-03-19
DE19637043A1 (en) 1998-03-19
CN1087293C (en) 2002-07-10
WO1998011082A1 (en) 1998-03-19
KR20000036063A (en) 2000-06-26

Similar Documents

Publication Publication Date Title
GB2346879A (en) Preparation of 3-substituted adenines and imidazo pyridines
EP0691327A4 (en) Amine derivative and dermatologic preparation containing the same
AU2344195A (en) Acylated aminophenylsulphonylureas, process for their preparation and their use as herbicides and plant-growth regulators
KR940002942B1 (en) Process for preparing antimycotic nail varnish
AU649849B2 (en) New vanadium complexes, process for preparing them and pharmaceutical compositions containing them
MX9606331A (en) Novel compound, process for producing the same, and antitumor agent.
MX9604020A (en) Arylalkyldiazinones.
CA2212326A1 (en) O-carbamoyl-(d)-phenylalanilol compounds and process for preparing the same
AU4384197A (en) New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds
BG100661A (en) Aryl acetic acid derivatives
MY107819A (en) Preparation of substituted piperidines.
CY1107599T1 (en) OCTHOD-6, 10-DIOXO-6H-PYRODEN [1,2-A] [1,2] DIAZEPIN-1-CARBOXYLIC ACID PRODUCER, THEIR PROCESSING PROCESS THEREOF
UA35556C2 (en) process for the preparation of hydrocortisone AND INTERMEDIATE compounds in the synthesis of hydrocortisone
ATE183190T1 (en) ERYTHROMYCIN DERIVATIVES, THEIR PROCESS FOR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
CA2228939A1 (en) Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
YU25699A (en) Novel erythromycin derivatives, method for preparing them and their use
GR1003725B (en) Bifunctional agents possessing antioxidant and antiarrhythmic activity
EP0369398A3 (en) Polyphosphazene derivatives containing carbonyl groups suitable for photoreticulation processes
MX9605400A (en) Novel tetrapeptides, their manufacture and use.
CA2032303A1 (en) Inhibitors of retroviral proteases
TW221443B (en)
AU2356501A (en) Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
MY107258A (en) 1-methoxypyrimidinyl-n-nitrophenyl-1h-1,2,4-triazole-3- sulphonamides, processes for their preparation and their use as herbicides.
WO1998055513A8 (en) New carbohydrates and use thereof
ES8604081A1 (en) Process for dimerizung a conjugated diene.

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)